PROCEPT BioRobotics Corporation Common Stock PRCT
$17.82
-1.85%
at last close
Market Cap$1.04 billion
P/E Ratio—
Div Yield—
Volume483.4K
52-Week Range
$16.66$40.10
Analyst Ratings
- Consensus
- Hold — 6 Buy · 6 Hold · 1 Sell (13 analysts)
- Avg. Price Target
- $28.64 (+60.7% upside)
Key Stats
- Today's Range
- $17.77 – $18.67
- 50-Day Range
- $16.74 – $22.93
- 52-Week Range
- $16.66 – $40.10
- Volume
- 483K shs
- Average Volume
- 1.39 million shs
- Market Cap
- $1.04 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.43%
- Days to Cover
- 1.00
About PROCEPT BioRobotics Corporation Common Stock
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Related Stocks
Compare head-to-head: PRCT vs SYK·PRCT vs BSX·PRCT vs RMD·PRCT vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.